Using a variety of nanoparticles composed of different chemical compositions, different groups are exploring proof-of-concept approaches for the delivery of different antineoplastic drugs, oligonucleotides, genes, and magnetic resonance imaging contrast agents.
The study provides a proof-of-concept approach to link lidar data in the parameterization of a RAPID model for temporal image reconstruction in forest dominated areas.
This study demonstrates a proof-of-concept approach for encapsulating the Pt NPs and bubbles into alginate particles utilizing simple reduction and hydrolysis reactions.
By the demonstration of producing a nanotube array, this proof-of-concept approach opens a new pathway to fabricate high-performance carbon nanotube arrays with controllable morphology for practical applications.
The recent publication of Davidovich-Rikanati et al. demonstrates the technical feasibility of the genetical engineering of pathways in tomato plants to modify their fruit flavour profile in a proof-of-concept approach.
The study provides a proof-of-concept approach to link lidar and MODIS data in the parameterization of RAPID models for high temporal and spatial resolutions of image reconstruction in forest dominated areas.
With aim to develop effective proof-of-concept approach which can be used in a development of new preparations for the inhalation therapy, we designed a new screening method for simple and rapid simultaneous determination of antibacterial potential of plant volatiles in the liquid and the vapour phase at different concentrations.
As a proof-of-concept approach to combining probabilities, the TFAC predictor was generated by taking the mean of the mean-centered probability values generated by the four individual chemotherapy sensitivity signatures.
It is a proof-of-concept approach to the question of whether two different gauge needles would affect the pain experienced by patients undergoing an ABG analysis.
We have developed a proof-of-concept approach for scoring, and prioritizing putative drug drug-event associations basedrug drug-event of cmplementassociations across multiple sources.
Our work illustrates a proof-of-concept approach for signal generation that can enable standardized surveillance of specific health outcomes of interest across all medical products.
